Patents Assigned to Upsher-Smith Laboratories, Inc.
  • Testosterone gel compositions and related methods
    Patent number: 9662340
    Abstract: Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: May 30, 2017
    Assignee: UPSHER-SMITH LABORATORIES, INC.
    Inventor: Harish K. Pimplaskar
  • EXTENDED-RELEASE TOPIRAMATE CAPSULES
    Publication number: 20170119808
    Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).
    Type: Application
    Filed: November 21, 2016
    Publication date: May 4, 2017
    Applicant: Upsher-Smith Laboratories, Inc.
    Inventors: Sarah Michelle BETTERMAN, Jaidev Srinivas TANTRY, Laura Marie PATRICK
  • Extended-release topiramate capsules
    Patent number: 9555005
    Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: January 31, 2017
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
  • TESTOSTERONE GEL COMPOSITIONS AND RELATED METHODS
    Publication number: 20160310508
    Abstract: Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.
    Type: Application
    Filed: March 25, 2016
    Publication date: October 27, 2016
    Applicant: Upsher-Smith Laboratories, Inc.
    Inventor: Harish K. Pimplaskar
  • Dermatological compositions and methods
    Patent number: 9456970
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: October 4, 2016
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Gloria A. Rood, Kenneth L. Evenstad, Victoria A. O'Neill
  • Sustained-released product comprising a combination of a non-opioid amine and a non-steroidal, anti-inflammatory drug
    Patent number: 9456985
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: October 4, 2016
    Assignee: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Sean B. Mahoney, Stephen M. Berge
  • Testosterone gel compositions and related methods
    Patent number: 9295675
    Abstract: Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: March 29, 2016
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventor: Harish K. Pimplaskar
  • Sustained Release Composition Comprising an Amine as Active Agent and a Salt of a Cyclic Organic Acid
    Publication number: 20160051475
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an amine-containing compound (e.g., an opioid) (including salts thereof) and a pharmaceutically acceptable salt of a non-NSAID cyclic organic acid compound.
    Type: Application
    Filed: September 11, 2015
    Publication date: February 25, 2016
    Applicant: Upsher-Smith Laboratories, Inc.
    Inventors: Ronnie Ortiz, James S. Jensen, Kristopher R. Lundell, Victoria Ann O'Neill, Sean Mahoney
  • DERMATOLOGICAL COMPOSITIONS AND METHODS
    Publication number: 20160000672
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Application
    Filed: September 11, 2015
    Publication date: January 7, 2016
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: GLORIA A. ROOD, KENNETH L. EVENSTAD, VICTORIA A. O'NEILL
  • EXTENDED-RELEASE TOPIRAMAGE CAPSULES
    Publication number: 20150265544
    Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).
    Type: Application
    Filed: June 5, 2015
    Publication date: September 24, 2015
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
  • Sustained-Released Product Comprising a Combination of a Non-Opioid Amine and a Non-Steroidal, Anti-Inflammatory Drug
    Publication number: 20150238423
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Application
    Filed: April 28, 2015
    Publication date: August 27, 2015
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: CHRISTIAN F. WERTZ, JAMES S. JENSEN, VICTORIA ANN O'NEILL, SEAN B. MAHONEY, STEPHEN M. BERGE
  • Extended-release topiramate capsules
    Patent number: 9101545
    Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 11, 2015
    Assignee: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
  • Sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug
    Patent number: 9023390
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: May 5, 2015
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Sean B. Mahoney, Stephen M. Berge
  • Opioid-containing oral pharmaceutical compositions and methods
    Patent number: 8987291
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: March 24, 2015
    Assignee: Upsher Smith Laboratories, Inc.
    Inventors: Kenneth L. Evenstad, Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Stephen M. Berge
  • Extended-release topiramate capsules
    Patent number: 8889190
    Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).
    Type: Grant
    Filed: January 17, 2014
    Date of Patent: November 18, 2014
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
  • EXTENDED-RELEASE TOPIRAMATE CAPSULES
    Publication number: 20140287037
    Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).
    Type: Application
    Filed: January 17, 2014
    Publication date: September 25, 2014
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
  • EXTENDED-RELEASE TOPIRAMATE CAPSULES
    Publication number: 20140271839
    Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: Upsher-Smith Laboratories, Inc.
    Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
  • Testosterone gel compositions and related methods
    Patent number: 8785426
    Abstract: Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.
    Type: Grant
    Filed: February 11, 2014
    Date of Patent: July 22, 2014
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventor: Harish K. Pimplaskar
  • Extended-release topiramate capsules
    Patent number: 8652527
    Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).
    Type: Grant
    Filed: March 19, 2013
    Date of Patent: February 18, 2014
    Assignee: Upsher-Smith Laboratories, Inc
    Inventors: Sarah Michelle Betterman, Jaidev Srinvas Tantry, Laura Marie Patrick
  • OPIOID-CONTAINING ORAL PHARMACEUTICAL COMPOSITIONS AND METHODS
    Publication number: 20130123293
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).
    Type: Application
    Filed: December 14, 2012
    Publication date: May 16, 2013
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventor: UPSHER-SMITH LABORATORIES, INC.